Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating hepatitis B

A drug, hepatitis B technology, applied in the field of drugs for the treatment of hepatitis B, can solve the problems of human adverse reactions, easy recurrence of the disease, and large side effects, and achieve the effects of protecting the liver, reducing treatment costs and pressure, and shortening the course of treatment

Inactive Publication Date: 2020-11-24
鞠秀英
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is currently the most serious infectious disease that endangers people's health. At present, there is no certain specific drug. The existing therapeutic drugs are mainly divided into antiviral drugs, immunomodulatory drugs and liver cell protection drugs. Most of them are western medicines. Adverse reactions in human body, or the disease is easy to relapse after stopping use, and the price is expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1: a kind of medicine for the treatment of hepatitis B, it is made up of the medicine of following parts by weight:

[0030] Thyme 30-50g, Dongbasil 5-15g, corn flower 30-50g, tiger eye 5-10g, knotweed 5-10g.

[0031] The method of use is as follows: weigh each drug component according to the amount, put it in a casserole, add water, boil it in high heat for 10 minutes, and wait for it to cool down for later use. The weight ratio of drug to water is 20:6000, which is 20g The medicine is added the water of 6000g.

[0032] The patient puts the above-mentioned boiled medicine in a refrigerator and stores it for drinking instead of tea.

[0033] The typical case of the hepatitis B patient cured by the present invention is as follows:

[0034] Case 2: Lee, man, 50 years old, people from Junan County, before it adopts the present invention, go to Junan County People's Hospital to check, in conjunction with its hepatitis B two-and-a-half inspection result and magn...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a medicine for treating hepatitis B. The medicine comprises the following components: thyme, elsholtzia bodinieri vaniot, flos dichroae, Indian damnacanthus herb and polygonum cuspidatum. The medicine is prepared from pure natural and low-cost pure plant Chinese herbal medicines, is natural, does not have any toxic or side effect or adverse reaction, is simple and feasible in application method, and can be used for greatly reducing the treatment cost and pressure of patients. The medicine components in the formula are reasonable in compatibility and can achieve a synergistic effect, so that the medicine has the effects of nourishing yin and soothing liver, tonifying qi and removing toxicity, promoting antibody generation and improving the immunologic function, achieves the aim of protecting liver, and is low in relapse rate after healing.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine compositions, in particular to a medicine for treating hepatitis B. Background technique [0002] Hepatitis B, the modern medical name, is an infectious disease caused by hepatitis B virus. The hepatitis B virus is the causative agent of hepatitis B. At least three antigens have been found in the process of hepatitis B virus infection. [0003] 1. Hepatitis B surface antigen (HBsAg) can induce the body to produce corresponding antibodies (anti-HBs). [0004] 2. Hepatitis B core antigen (HBsAg) exists in the nucleus, and free (HBcAg) and its corresponding antibody (anti-HBc) cannot be detected in the blood circulation. [0005] 3. Hepatitis B e antigen (HBeAg) can be used as an important indicator of hepatitis B replication in the body and serum infectivity, and its corresponding antibody (anti-HBe). [0006] People are all susceptible to hepatitis B virus. In susceptible populations...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/704A61P1/16A61P31/20
CPCA61K36/47A61K36/48A61K36/53A61K36/704A61K2236/331A61P1/16A61P31/20A61K2300/00
Inventor 鞠秀英
Owner 鞠秀英
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com